LiDCO Group plc (LON:LID)‘s stock had its “corporate” rating reaffirmed by research analysts at FinnCap in a research note issued to investors on Tuesday. They currently have a GBX 14 ($0.18) target price on the stock. FinnCap’s price target points to a potential upside of 98.44% from the stock’s previous close.
LiDCO Group plc (LID) opened at GBX 7.06 ($0.09) on Tuesday. LiDCO Group plc has a 12-month low of GBX 5.50 ($0.07) and a 12-month high of GBX 10.25 ($0.13).
About LiDCO Group plc
LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.
Receive News & Ratings for LiDCO Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group plc and related companies with MarketBeat.com's FREE daily email newsletter.